These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

683 related items for PubMed ID: 21724247

  • 1. The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.
    Cruz LJ, Tacken PJ, Fokkink R, Figdor CG.
    Biomaterials; 2011 Oct; 32(28):6791-803. PubMed ID: 21724247
    [Abstract] [Full Text] [Related]

  • 2. Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro.
    Cruz LJ, Tacken PJ, Fokkink R, Joosten B, Stuart MC, Albericio F, Torensma R, Figdor CG.
    J Control Release; 2010 Jun 01; 144(2):118-26. PubMed ID: 20156497
    [Abstract] [Full Text] [Related]

  • 3. Multimodal imaging of nanovaccine carriers targeted to human dendritic cells.
    Cruz LJ, Tacken PJ, Bonetto F, Buschow SI, Croes HJ, Wijers M, de Vries IJ, Figdor CG.
    Mol Pharm; 2011 Apr 04; 8(2):520-31. PubMed ID: 21381651
    [Abstract] [Full Text] [Related]

  • 4. Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN.
    Cruz LJ, Tacken PJ, Pots JM, Torensma R, Buschow SI, Figdor CG.
    Biomaterials; 2012 Jun 04; 33(16):4229-39. PubMed ID: 22410170
    [Abstract] [Full Text] [Related]

  • 5. Antibodies and carbohydrate ligands binding to DC-SIGN differentially modulate receptor trafficking.
    Tacken PJ, Ter Huurne M, Torensma R, Figdor CG.
    Eur J Immunol; 2012 Aug 04; 42(8):1989-98. PubMed ID: 22653683
    [Abstract] [Full Text] [Related]

  • 6. Target-specific cellular uptake of taxol-loaded heparin-PEG-folate nanoparticles.
    Wang Y, Wang Y, Xiang J, Yao K.
    Biomacromolecules; 2010 Dec 13; 11(12):3531-8. PubMed ID: 21086982
    [Abstract] [Full Text] [Related]

  • 7. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S, Poulin S, Hildgen P.
    J Biomed Mater Res A; 2008 Dec 15; 87(4):885-95. PubMed ID: 18228249
    [Abstract] [Full Text] [Related]

  • 8. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S, Rabanel JM, Hildgen P.
    Int J Pharm; 2011 Jun 15; 411(1-2):178-87. PubMed ID: 21458551
    [Abstract] [Full Text] [Related]

  • 9. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK, Stephani J, Schaefer M, Kalay H, García-Vallejo JJ, den Haan J, Saeland E, Sparwasser T, van Kooyk Y.
    Mol Immunol; 2009 Dec 15; 47(2-3):164-74. PubMed ID: 19818504
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH, Wang YC, Huang HY, Wu LC, Yang CS.
    Nanotechnology; 2011 May 06; 22(18):185601. PubMed ID: 21415469
    [Abstract] [Full Text] [Related]

  • 12. DC-SIGN mediated antigen-targeting using glycan-modified liposomes: formulation considerations.
    Joshi MD, Unger WW, van Beelen AJ, Bruijns SC, Litjens M, van Bloois L, Kalay H, van Kooyk Y, Storm G.
    Int J Pharm; 2011 Sep 20; 416(2):426-32. PubMed ID: 21371544
    [Abstract] [Full Text] [Related]

  • 13. In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models.
    Kretz-Rommel A, Qin F, Dakappagari N, Torensma R, Faas S, Wu D, Bowdish KS.
    J Immunother; 2007 Oct 20; 30(7):715-26. PubMed ID: 17893564
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Epitope mapping on the dendritic cell-specific ICAM-3-grabbing non-integrin (DC-SIGN) pathogen-attachment factor.
    Sierra-Filardi E, Estecha A, Samaniego R, Fernández-Ruiz E, Colmenares M, Sánchez-Mateos P, Steinman RM, Granelli-Piperno A, Corbí AL.
    Mol Immunol; 2010 Jan 20; 47(4):840-8. PubMed ID: 19879650
    [Abstract] [Full Text] [Related]

  • 16. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q, Chen X, Jia J, Zhang W, Yang T, Wang L, Ma G.
    ACS Nano; 2015 May 26; 9(5):4925-38. PubMed ID: 25898266
    [Abstract] [Full Text] [Related]

  • 17. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate.
    Kim SH, Jeong JH, Chun KW, Park TG.
    Langmuir; 2005 Sep 13; 21(19):8852-7. PubMed ID: 16142970
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.
    Chen J, Li S, Shen Q, He H, Zhang Y.
    Drug Dev Ind Pharm; 2011 Nov 13; 37(11):1339-46. PubMed ID: 21524153
    [Abstract] [Full Text] [Related]

  • 20. Tracking targeted bimodal nanovaccines: immune responses and routing in cells, tissue, and whole organism.
    Cruz LJ, Tacken PJ, Zeelenberg IS, Srinivas M, Bonetto F, Weigelin B, Eich C, de Vries IJ, Figdor CG.
    Mol Pharm; 2014 Dec 01; 11(12):4299-313. PubMed ID: 25290882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.